We are live on ! Find out more
MCA

Martin Capital Advisors Portfolio holdings

AUM $191M
1-Year Est. Return 42.42%
This Fund
S&P 500
This Quarter Est. Return
+28.49%
1 Year Est. Return
+42.42%
3 Year Est. Return
+117.16%
5 Year Est. Return
10 Year Est. Return
AUM
$191M
AUM Growth
+$32.4M
Cap. Flow
+$3.61M
Cap. Flow %
1.89%
Top 10 Hldgs %
58.17%
Holding
78
New
5
Increased
34
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$272K
2
ADI icon
Analog Devices
ADI
+$209K
3
DELL icon
Dell
DELL
+$184K
4
AMD icon
Advanced Micro Devices
AMD
+$168K
5
ASML icon
ASML
ASML
+$167K

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$237K
2
USPH icon
US Physical Therapy
USPH
+$72K
3
TSCO icon
Tractor Supply
TSCO
+$54.1K
4
QQQ icon
Invesco QQQ Trust
QQQ
+$49.5K
5
PYPL icon
PayPal
PYPL
+$27.5K

Sector Composition

Rank Sector Weight
1 Technology 49.02%
2 Healthcare 10.03%
3 Consumer Discretionary 9.89%
4 Financials 9.85%
5 Communication Services 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$39.6M 20.76%
136,849
+393
+0.3% +$112K
NVDA icon
2
NVIDIA
NVDA
$4.72T
$14.1M 7.39%
70,489
+544
+0.8% +$112K
LRCX icon
3
Lam Research
LRCX
$373B
$11.8M 6.2%
27,285
+77
+0.3% +$23.4K
QQQ icon
4
Invesco QQQ Trust
QQQ
$450B
$9.78M 5.13%
13,283
-72
-0.5% -$49.5K
ISRG icon
5
Intuitive Surgical
ISRG
$126B
$8.06M 4.22%
20,268
+232
+1% +$101K
VTI icon
6
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$6.77M 3.55%
18,295
-71
-0.4% -$25.4K
WSM icon
7
Williams-Sonoma
WSM
$27.5B
$5.85M 3.07%
25,094
+582
+2% +$115K
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.08T
$5.53M 2.9%
15,464
+252
+2% +$90.7K
MA icon
9
Mastercard
MA
$510B
$5.16M 2.7%
10,046
+210
+2% +$105K
COST icon
10
Costco
COST
$423B
$4.31M 2.26%
4,608
+103
+2% +$103K
V icon
11
Visa
V
$684B
$4.09M 2.14%
11,909
+341
+3% +$109K
TXN icon
12
Texas Instruments
TXN
$255B
$3.56M 1.87%
11,960
+428
+4% +$119K
SBUX icon
13
Starbucks
SBUX
$121B
$3.28M 1.72%
32,114
-15
-0% -$1.51K
AMZN icon
14
Amazon
AMZN
$2.53T
$2.74M 1.44%
11,495
+269
+2% +$67.5K
SCHW
15
Charles Schwab
SCHW
$181B
$2.59M 1.36%
28,119
ORCL icon
16
Oracle
ORCL
$367B
$2.56M 1.34%
17,438
+653
+4% +$118K
IBB icon
17
iShares Biotechnology ETF
IBB
$9.52B
$2.55M 1.34%
13,419
EW icon
18
Edwards Lifesciences
EW
$50B
$2.49M 1.3%
27,473
+1,247
+5% +$104K
CAT icon
19
Caterpillar
CAT
$373B
$2.42M 1.27%
2,270
+159
+8% +$140K
INTC icon
20
Intel
INTC
$460B
$2.35M 1.23%
16,804
XYZ
21
Block Inc
XYZ
$49.2B
$2.35M 1.23%
30,859
-272
-0.9% -$19.1K
VCSH icon
22
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$2.2M 1.15%
27,800
-60
-0.2% -$4.74K
IDXX icon
23
Idexx Laboratories
IDXX
$44.1B
$2.17M 1.14%
4,113
BLK icon
24
Blackrock
BLK
$170B
$2.12M 1.11%
2,201
+103
+5% +$107K
AMAT icon
25
Applied Materials
AMAT
$398B
$2.08M 1.09%
2,873
+283
+11% +$131K

Similar funds

Martin Capital Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Martin Capital Advisors held 78 positions worth $191M, up 20% from $158M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Martin Capital Advisors's Q2 2026 filing shows 5 new, 34 increased, 16 reduced and 1 closed positions. Its largest new stake was Axon Enterprise: 651 shares worth $365K. The largest sale was Zoetis, an estimated $237K.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Martin Capital Advisors's largest Q2 2026 buy was Axon Enterprise: 651 shares worth $365K.
  • Martin Capital Advisors added most to Advanced Micro Devices in Q2 2026, an estimated $168K increase.
  • Martin Capital Advisors's biggest Q2 2026 reduction was US Physical Therapy, cutting an estimated $72K.
  • Martin Capital Advisors fully exited Zoetis in Q2 2026, selling an estimated $237K.
  • Martin Capital Advisors's ten largest holdings make up 58% of its $191M portfolio in Q2 2026.
  • Martin Capital Advisors opened 5 new positions and closed 1 in Q2 2026.
  • Martin Capital Advisors's portfolio value rose 20% quarter-over-quarter to $191M.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.